The National Academies Testimony before Congress

Public Laws Containing Studies for the National Academies

Briefings to Congress

Congressionally Mandated Reports

Policy Statements and Historical Documents

The OCGA staff

THE NATIONAL ACADEMIES
Institute of Medicine
Board on Global Health
Committee on Understanding the Global Public Health Implications
of Substandard, Falsified, and Counterfeit Medical Products

*****

Congressional Briefings
Monday, February 11, 2013
2322 Rayburn House Office Bldg. – 2:00 p.m.
and
430 Dirksen Senate Office Bldg. – 3:00 p.m.

on

Countering the Problem of Falsified and Substandard Drugs

This new report, from the Institute of Medicine, explores the magnitude and impact of illegitimate, poor-quality medications and recommends steps to improve countries' capacity to regulate the production and distribution of drugs, detect fake or subpar products, and close gaps that allow products to be falsified or diluted.

These series of briefings were for members of Congress and congressional staff only. The report was publicly released on February 13, 2013 and can be found, in its entirety, on the Web site of the National Academies Press.